로딩 중…
지수 로딩 중…
JEIL PHARMA HOLDINGS INC.
002620· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩7,180+3.01%
2026-08-04
Financials
Valuation Metrics
JEIL PHARMA HOLDINGS INC.'s Market Cap is ₩1147B. At end of 2025 it was ₩1284B. Ranked #1142 of 2,436 in KR market (top 47%), #551 of 787 on KOSPI (top 70%), #134 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 57%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 114.69B KRW | KR#1,142/2,436 Sec#134/234 |
| Revenue | 625.97B KRW | KR#531/2,436 Sec#22/234 |
| Net Income | 34.52B KRW | KR#469/2,436 Sec#31/234 |
| Total Assets | 878.26B KRW | KR#503/2,436 Sec#27/234 |
| Net Assets | 475.12B KRW | KR#520/2,436 Sec#31/234 |
| Employees | 36 | KR#2,137/2,436 Sec#196/234 |
| Value | ||
| P/E | 3.32x | KR#139/2,436 Sec#6/234 |
| P/B | 0.24x | KR#201/2,436 Sec#5/234 |
| P/S | 0.18x | KR#319/2,436 Sec#4/234 |
| EV/EBITDA | 6.39x | KR#329/2,436 Sec#11/234 |
| FCF Yield | -6.88% | KR—/2,436 Sec—/234 |
| Profitability | ||
| ROE | 7.27% | KR#760/2,436 Sec#52/234 |
| ROA | 3.93% | KR#804/2,436 Sec#70/234 |
| Op. Margin | 5.61% | KR#846/2,436 Sec#68/234 |
| Revenue Growth | -17.38% | KR#2,023/2,436 Sec#183/234 |
| Earnings Growth | -2.74% | KR#921/2,436 Sec#62/234 |
| Financial Health | ||
| Debt Ratio | 84.85% | KR#277/2,436 Sec#37/234 |
| Total Debt | 167.50B KRW | KR#545/2,436 Sec#28/234 |
| FCF | -7.89B KRW | KR#1,638/2,436 Sec#135/234 |
| Cash | 57.60B KRW | KR#684/2,436 Sec#37/234 |
| Current Ratio | 1.22x | KR#1,559/2,436 Sec#162/234 |
| Net Debt/EBITDA | 3.13x | KR#963/2,436 Sec#71/234 |
| Dividend | ||
| Div. Yield | 1.00% | KR#1,139/2,436 Sec#67/234 |
| Div. Growth | 40.00% | KR#276/2,436 Sec#13/234 |
| Performance | ||
| 1Y Return | -15.33% | KR#1,116/2,436 Sec#85/234 |
| 1M Return | 7.00% | KR#376/2,436 Sec#28/234 |
| From 52W High | -27.11% | KR#315/2,436 Sec#18/234 |
| 1Y MDD | -32.22% | KR#271/2,436 Sec#17/234 |
| Trading | ||
| Volume | 1,466 shares | KR#2,357/2,436 Sec#230/234 |
| Foreign Own. | 9.84% | KR#473/2,436 Sec#41/234 |
| Per Share | ||
| EPS | 841 KRW | KR#698/2,436 Sec#49/234 |
| BPS | 20,807 KRW | KR#496/2,436 Sec#34/234 |
Company Info
동사는 1959년 설립되어 1988년 상장된 제약 지주회사로, 2017년 인적분할을 통해 제일파마홀딩스와 제일약품으로 분리되었음. 종속법인으로 제일약품, 제일헬스사이언스, 제일앤파트너스를 보유하며, 투자수익, 브랜드수수료, 경영자문수수료, 임대수익 등 지주회사 사업을 하고 있음. 투명한 기업지배구조를 바탕으로 관리 효율화를 통해 자회사들의 자율 경영과 책임경영을 발전시키고 있음. 제일파마홀딩스는 1959년에 설립되었으며 서울특별시 서초구에 본사를 두고 있습니다.